The overall costs to healthcare systems of treating these conditions is significant and there is a huge potential to reduce healthcare costs by reducing overall levels of obesity and Type 2 diabetes
Food and Drug Administration (FDA) to discuss its clinical development program and manufacturing scale-up plans for its lead investigational drug MTX-001, for the treatment of venous leg ulcers
According to the investigation by Channel 4s Dispatches program, pharmacies are issuing prescriptions too liberally
Hypoglycemia (Low Blood Sugar) Since Wegovy increases insulin secretion, there is a risk that your blood sugar can be lowered to dangerous levels
In the ATTAIN-1 phase 3, randomized trial, the use of orforglipron, an oral glucagon-like peptide-1 receptor agonist, led to significant mean body-weight reductions in patients with obesity, as compared with placebo
They do this by mimicking the chemical glucagon-like peptide-1 (GLP-1) that the small intestine produces to target gut hormone receptors
